Hims vs Fridays: Comparing Two GLP-1 Telehealth Models

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where we unpack GLP-1 therapy, weight-management protocols, and the inherited biology that quietly shapes how each program lands for a given person. Browse all Peptides & GLP-1 education

This review is editorially independent. PlexusDx holds no commercial relationship with Hims, its parent company, or any brand named here, and nothing below is an affiliate placement.

Search "Hims vs Fridays" and you are really weighing two very different company shapes that happen to overlap on one product line. Hims is a broad, multi-category telehealth brand; Fridays is a narrower, weight-focused program. This piece walks through how each is built, what that means for a GLP-1 buyer, and the inherited variable neither one measures. Written as of April 2026.

Full head-to-head: PlexusDx vs Fridays →

Two very different footprints

The clearest distinction here is scope. Hims & Hers Health markets across many wellness categories, with weight care sitting alongside a wide catalog, whereas Fridays Health concentrates on the metabolic lane. That structural difference — generalist platform versus focused program — shapes onboarding, support depth, and how each brand talks about GLP-1 care long before any prescription is written.

How Hims frames its weight offer

Hims runs on a subscription-telehealth model: a virtual clinical evaluation, a provider-issued prescription, and fulfillment that may involve either FDA-approved brand GLP-1 products or compounded semaglutide and tirzepatide routed through a licensed 503A compounding pharmacy pathway. Program specifics shift over time, so the current terms live on Hims's official website.

How Fridays frames its weight offer

Fridays pairs telehealth with a compounded-pharmacy pathway. The medication menu, eligibility rules, and plan tiers can change, so anyone weighing the two should confirm the live details on Fridays's official website rather than trusting a static summary.

Where the pricing conversation lands

On its own pricing page (joinfridays.com/pricing, checked 2026-07-20), Fridays lists compounded semaglutide at $249/mo and compounded tirzepatide at $359/mo on a month-to-month basis, with no membership fee, free shipping, and coaching plus dietitian support folded in; prepaid annual plans drop the effective rate to roughly $150/mo for semaglutide and $240/mo for tirzepatide. Those numbers shifted noticeably inside a single day, so treat any figure as provisional and verify before you commit. Hims publishes its own pricing separately. For reference, PlexusDx month-to-month sits about $60–$70/mo under Fridays' month-to-month on both compounds, while Fridays' prepaid 3- and 6-month bundles come in lower per month.

The evidence sitting under both brands

Whatever logo is on the box, the pharmacology traces back to the compound class: GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, plus the GIP/GLP-1 dual agonist tirzepatide. The anchoring trials are STEP (semaglutide for weight management, NEJM 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Effect sizes track the molecule and dose, not the storefront delivering it.

The genetic layer neither platform maps

Where both Hims and Fridays stop is upstream, at the inherited architecture that sets your metabolic starting point. Variants in FTO (fat-mass and obesity-associated), GLP1R (the receptor every GLP-1 compound targets), MC4R (a melanocortin receptor tied to satiety), and TCF7L2 (a transcription factor linked to glucose handling) describe the terrain a clinician prescribes into. They are pathway-level markers — they never predict how you will respond to a particular compound, but they do sketch the biology in play. That is the gap PlexusDx fills: the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across FTO, MC4R, and TCF7L2, and PlexusDx offers semaglutide and tirzepatide directly through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Testing before you invest turns a blind prescription into an informed conversation with your provider.

No affiliation: PlexusDx is independent of Hims and has no commercial tie to any company examined in this review.

More from the PlexusDx Education Hub: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, GLP 1 What Is.

Editorial disclaimer: this comparison is educational, not a purchase recommendation. PlexusDx is not affiliated with Hims and sells semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test maps how your genes influence peptide-related pathways and does not predict response to any specific medication. Talk with a qualified healthcare provider before starting any peptide protocol.

See the two paths side by side: explore the Weight Management Protocols, or begin upstream with the Precision Peptide Genetic Test to read your GLP-1 pathway before you choose.

Frequently Asked Questions

Is Hims or Fridays the right fit for weight care?

Neither wins outright. Hims is a broad telehealth brand with weight care as one line among many; Fridays is a focused metabolic program. Fit depends on whether you want a generalist platform or a weight-specific service, plus cost, medication menu, and provider model. Compare each brand's live terms directly.

Do Hims and Fridays use the same medications?

Both can prescribe GLP-1 receptor agonists through telehealth, sourced as FDA-approved brand products or compounded semaglutide and tirzepatide via a licensed pharmacy. The molecule drives the pharmacology in either case; the platform decides the dispensing route, the subscription shape, and the support wrapped around the prescription.

Does the Precision Peptide Genetic Test say which program will work?

No. It never predicts response to a compound, a brand, or a telehealth service. It reads pathway-level variants in FTO and MC4R, and TCF7L2 that describe your baseline GLP-1 biology — context that stays relevant no matter which program ultimately writes the prescription for you.

How is the PlexusDx approach different from both?

PlexusDx pairs its own semaglutide and tirzepatide protocols with upstream genetic context from the Precision Peptide Genetic Test. The differentiator is pathway-level insight into FTO, MC4R variants — a layer Hims, Fridays, and most telehealth-only programs do not place beside the medication itself.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.